文献速递临床血液与体液临床免疫分子诊断

改良血浆基细胞块技术用于体液和细针穿刺样本的验证

Validation of a modified plasma-based cell block technique using activated partial thromboplastin time-ellagic acid reagent in body fluid and fine needle aspiration samples in cytology.
PubMed 文献 · Am J Clin Pathol · 2026-01-01

该前瞻性研究用新鲜患者血浆和活化部分凝血活酶时间-鞣花酸试剂制备细胞块,评估其在59例体液和细针穿刺样本中的细胞保存和辅助检测效用。结果显示体液样本细胞块与涂片诊断一致率为92.6%,细针穿刺样本为43.75%,免疫组化染色强阳性占90.0%且无背景染色。该方法可提高诊断率并兼容多种辅助检测,适合低资源实验室。

要点

  • 改良血浆基细胞块在体液样本中诊断一致率达92.6%,细胞保存良好。
  • 细针穿刺样本细胞块诊断一致率仅43.75%,但75.0%含代表性材料。
  • 免疫组化强染色占90.0%,背景清晰,特殊染色和分子检测可行。

核心结论

  • 改良血浆基细胞块技术可提高诊断率并保存形态,兼容免疫组化和常用分子检测,是可行且成本有效的替代方法。

研究设计与样本

  • 前瞻性研究,使用新鲜患者血浆和活化部分凝血活酶时间-鞣花酸试剂制备细胞块,共纳入64例样本,59例符合入选标准。

主要发现

  • 体液样本细胞块与涂片诊断一致率为92.6%,细针穿刺样本为43.75%。
  • 体液沉淀细胞块中92.5%具有代表性,退化轻微且结构极佳。
  • 细针穿刺细胞块中75.0%含代表性材料,81.25%退化轻微至中度,58.3%结构保存极佳。
  • 9例免疫组化中90.0%显示强染色,86.9%清晰度良好,无背景染色。

临床怎么用

  • 在低资源实验室可采用该血浆基细胞块方法进行体液和细针穿刺样本的细胞学诊断及免疫组化等辅助检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Despite the availability of different cell block preparation techniques in the literature, there is an unmet need for a technique that meets the needs of a low-tech, low-resource laboratory for diagnostic and ancillary testing. We aimed to develop and validate a modified method of cell block preparation in terms of its efficacy in cellular preservation and its utility in ancillary testing. METHODS: Cell blocks were prepared using fresh patient plasma and activated partial thromboplastin time-ellagic acid reagent. A prospective study was conducted to assess the performance of this modified plasma-based cell block in terms of (1) cell yield as well as morphologic and architectural preservation and (2) utility of the modified plasma-based cell block in immunohistochemistry in terms of preservation of antigenicity, staining quality, and the presence of background interference. Special stains and molecular testing were performed in select cases. RESULTS: Of the 64 samples we included, 59 met the inclusion criteria. Diagnostic concordance between cell block and smear was 92.6% in body fluids and 43.75% in fine needle aspiration cytologic aspirates. Among fluid sediment modified plasma-based cell blocks, 92.5% were representative, with minimal degeneration and excellent architecture, whereas fine needle aspiration cytologic modified plasma-based cell blocks showed representative material in 75.0%, minimal to moderate degeneration in 81.25%, and excellent architectural preservation in 58.3% of blocks. Immunohistochemistry performed in 9 cases showed strong staining in 90.0% and good clarity in 86.9% of cases, with no background staining. Special stains and selective molecular tests were successfully performed. CONCLUSIONS: Modified plasma-based cell block testing improves diagnostic yield and preserves morphology. Compatible with a broad spectrum of ancillary testing, chiefly immunohistochemistry and commonly used molecular tests, it is a feasible and cost-effective alternative.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Kanna SM, Edupuganti HS, Shetty A, et al. Validation of a modified plasma-based cell block technique using activated partial thromboplastin time-ellagic acid reagent in body fluid and fine needle aspiration samples in cytology. Am J Clin Pathol. 2026. PMID: 42201993. doi:10.1093/ajcp/aqag053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。